13D Filing: Bay City Capital Fund V, L.P. and Sunesis Pharmaceuticals Inc (SNSS)

Names of
reporting persons:

BAY CITY CAPITAL FUND V, L.P.

Check the appropriate box if a member
of a group (see instructions):

(a)  ☒        (b)  ☐

SEC use only:

Source of funds (see
instructions):

WC

Check if disclosure of legal
proceedings is required pursuant to Items 2(d) or 2(e): ☐

Citizenship or place of
organization:

DELAWARE

Number of

shares

beneficially

owned by

each

reporting

person

with

Sole voting power:

0 SHARES OF COMMON STOCK

Shared voting power:

1,828,968 SHARES OF COMMON STOCK (A)

Sole dispositive power:

0 SHARES OF COMMON STOCK

Shared dispositive power:

1,828,968 SHARES OF COMMON STOCK (A)

Aggregate amount beneficially owned by each reporting person:

1,828,968 SHARES OF COMMON STOCK (A)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions): ☐

Percent of class represented by amount
in Row (11):

5.3% (B)

Type of reporting person (see
instructions):

PN